I-Corps: Bioengineered Chimeric Antigen Receptor (CAR) Chips for Screening CAR T-Cell Immunotherapy
I-Corps:用于筛选 CAR T 细胞免疫疗法的生物工程嵌合抗原受体 (CAR) 芯片
基本信息
- 批准号:2221959
- 负责人:
- 金额:$ 5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-01 至 2023-10-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The broader impact/commercial potential of this I-Corps project is the development of Chimeric Antigen Receptor (CAR) T-cell Chip technology to improve the success rate of cancer treatment and shorten the cycle of CAR T-cell immunotherapy, making the entire approach cost-effective and ultimately improving patient welfare. This technology may be especially impactful in low resource communities where current CAR T-cell treatments are unaffordable. Moreover, the CAR-T Chip technology may provide a paradigm shift in drug development: reducing development costs and improving the overall pass rate of newly developed CAR T-cell products in clinical trials. This I-Corps project is based on the development of an improved CAR T-cell therapy with a holistic analysis of the diverse, evolutionary immunosuppressive milieus in the bone marrow and a robust system to probe the interactions between CAR-T cells and the tumor immune microenvironment. Currently, conventional in vitro cell culture and animal models are used to study B-cell acute lymphoblastic lymphoma (B-ALL) pathophysiology and test CAR T-cell functionality. These methods fail to recapitulate the human immune system and thus their clinical full-flanged usage. The new microfluidics-based CAR-T Chip platform may provide a new avenue for screening and improving CAR T-cell therapy by recapitulating patient-specific leukemic bone marrow microenvironment on a chip. The proposed technology may enable a rapid, cost-effective, and high-throughput evaluation of patient-specific response to CAR T-cell immunotherapy, as well as alternative treatments.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
这个i-Corps项目的更广泛的影响/商业潜力是开发嵌合抗原受体(CAR)T细胞芯片技术,以提高癌症治疗的成功率,缩短CAR T细胞免疫治疗的周期,使整个方法具有成本效益,并最终改善患者的福利。这项技术可能在资源匮乏的社区特别有效,在那里,目前的CAR T细胞治疗负担不起。此外,CAR-T芯片技术可能会带来药物开发的范式转变:降低开发成本,提高新开发的CAR T细胞产品在临床试验中的总体合格率。这个I-Corps项目是基于一种改进的CAR T细胞疗法的开发,该疗法对骨髓中多样化的、进化的免疫抑制环境进行全面分析,并建立一个强大的系统来探索CAR-T细胞与肿瘤免疫微环境之间的相互作用。目前,研究B细胞急性淋巴母细胞性淋巴瘤(B-ALL)的病理生理学和检测CAR T细胞功能的方法主要采用常规的体外细胞培养和动物模型。这些方法未能概括人类免疫系统,从而无法全面应用于临床。新的基于微流控的CAR-T芯片平台通过在芯片上概括患者特定的白血病骨髓微环境,可能为筛选和改进CAR T细胞治疗提供一条新的途径。这项拟议的技术可以对CAR T细胞免疫疗法以及替代疗法的患者特异性反应进行快速、经济有效和高通量的评估。这一奖项反映了NSF的法定使命,并通过使用基金会的智力优势和更广泛的影响审查标准进行评估,被认为值得支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Weiqiang Chen其他文献
Robust Adaptive Fault Estimation and Fault Tolerant Control for Quadrotor Attitude System
四旋翼飞行器姿态系统鲁棒自适应故障估计与容错控制
- DOI:
10.1080/00207179.2018.1484573 - 发表时间:
- 期刊:
- 影响因子:2.1
- 作者:
Xiaohong Nian;Weiqiang Chen;Xiaoyan Chu;Zhiwei Xu - 通讯作者:
Zhiwei Xu
Effect of interface geometric parameters on the mechanical properties and damage evolution of layered cemented gangue backfill: Experiments and models
界面几何参数对层状胶结煤矸石充填体力学性能和损伤演化的影响:实验与模型
- DOI:
10.1016/j.conbuildmat.2022.128678 - 发表时间:
2022-09 - 期刊:
- 影响因子:7.4
- 作者:
Yiming Wang;Jiangyu Wu;Hai Pu;Weiqiang Chen;Qian Yin;Shuo Yang;Dan Ma - 通讯作者:
Dan Ma
The Radiation Enhancement of 15 nm Citrate-Capped Gold Nanoparticles Exposed to 70 keV/um Carbon Ions
15 nm 柠檬酸盐封端的金纳米粒子暴露于 70 keV/um 碳离子的辐射增强
- DOI:
- 发表时间:
2016 - 期刊:
- 影响因子:0
- 作者:
Xiaogang Zheng;Fei Ye;Weiqiang Chen;Qiang Li - 通讯作者:
Qiang Li
Clinical use of a neuronavigation system in hemangioblastoma resection of posterior cranial fossa
神经导航系统在颅后窝血管母细胞瘤切除术中的临床应用
- DOI:
10.3109/13645706.2011.611140 - 发表时间:
2012 - 期刊:
- 影响因子:1.7
- 作者:
Weiqiang Chen;Guangyu Zhang;Cai Lin;Ying;D. Cai;Mindong Huang;Yan;Chuwei Cai;Wang'an Li;Chong - 通讯作者:
Chong
Moiré Superlattice-Induced Superconductivity in One-Unit-Cell FeTe
单晶 FeTe 中莫尔超晶格诱导的超导性
- DOI:
10.1021/acs.nanolett.0c04048 - 发表时间:
2021 - 期刊:
- 影响因子:10.8
- 作者:
Hailang Qin;Xiaobin Chen;Bin Guo;Tianluo Pan;Meng Zhang;Bochao Xu;Junshu Chen;Hongtao He;Jiawei Mei;Weiqiang Chen;Fei Ye;Gan Wang - 通讯作者:
Gan Wang
Weiqiang Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Weiqiang Chen', 18)}}的其他基金
Bioengineering Leukemic Bone Marrow Niche for Dissecting the Heterogeneous Leukemia Chemo-resistance Mechanisms
用于剖析异质性白血病化疗耐药机制的生物工程白血病骨髓生态位
- 批准号:
2103219 - 财政年份:2021
- 资助金额:
$ 5万 - 项目类别:
Standard Grant
Collaborative Research: Plasmofluidic Nanoantenna-Superlens Biosensor for Single-Cell Functional Immunophenotyping
合作研究:用于单细胞功能免疫表型分析的质流控纳米天线-超级透镜生物传感器
- 批准号:
1701322 - 财政年份:2017
- 资助金额:
$ 5万 - 项目类别:
Standard Grant
相似海外基金
Developing bioengineered sugar beet for aphid resistance and virus control.
开发生物工程甜菜以抵抗蚜虫和控制病毒。
- 批准号:
10076420 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Grant for R&D
Bioengineered self-sealing synthetic arteriovenous graft for hemodialysis access
用于血液透析通路的生物工程自封闭合成动静脉移植物
- 批准号:
479454 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Operating Grants
PFI-RP: Advanced cryopreservation of complex bioengineered tissues
PFI-RP:复杂生物工程组织的高级冷冻保存
- 批准号:
2234490 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Standard Grant
Bioengineered Composite for the Treatment of Peripheral Arterial Disease
用于治疗外周动脉疾病的生物工程复合材料
- 批准号:
10639077 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Improving in vitro preantral follicle development using novel bioengineered culture systems and pre-theca-like cells as a strategy for assisted reproduction
使用新型生物工程培养系统和卵泡膜前样细胞作为辅助生殖策略改善体外窦前卵泡发育
- 批准号:
10749434 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Ex-vivo bioengineered technology to unravel dysfunction due to non-alcoholic steatohepatitis (NASH)
离体生物工程技术可解决非酒精性脂肪性肝炎 (NASH) 引起的功能障碍
- 批准号:
10744393 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Bioengineered corneal endothelial graft using photodegradable device to induce graft-host integration
使用光降解装置诱导移植物-宿主整合的生物工程角膜内皮移植物
- 批准号:
10719330 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
A Convergent Bioengineered Platform for Multifunctional Therapeutic Exosomes
多功能治疗性外泌体的融合生物工程平台
- 批准号:
10713513 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Optimising bioengineered structures for resilient shorelines and habitats
优化生物工程结构,打造有弹性的海岸线和栖息地
- 批准号:
IE230100498 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Early Career Industry Fellowships
Excellence in Research: Bioengineered extracellular vesicles from stem cells and macrophages act synergistically in angiogenesis
卓越的研究:来自干细胞和巨噬细胞的生物工程细胞外囊泡在血管生成中协同作用
- 批准号:
2302440 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Standard Grant